“A growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes.” (1)

ROCHESTER, NY, UNITED STATES, November 30, 2015 /EINPresswire.com/ --

“Infected with the herpes simplex virus (HSV-1 or HSV-2)? The CBCD recommends taking Gene-Eden-VIR or Novirin against the latent virus.” – Greg Bennett, CBCD

HSV-1 is commonly associated with oral herpes. However, HSV-1 is an increasingly common cause of genital herpes too. In fact, a study found that “fewer of today’s teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years. Without these antibodies, today’s teens may be more susceptible - when they become sexually active - to genital infections also caused by the virus, particularly through oral sex.” (1)

In the study mentioned above, which was conducted by the Centers for Disease Control and Prevention (CDC), “Dr. Bradley and her team found an overall HSV-1 seroprevalence of 54 percent during the period 2005 to 2010. Among 14 to 19 year olds, HSV-1 seroprevalence declined by nearly 23 percent from the 1999 to 2004 period compared to the 2005 to 2010 period. Among 20 to 29 year olds, HSV-1 seroprevalence declined by more than 9 percent. HSV-1 seroprevalence remained stable in the two oldest age groups (those in their 30s and 40s).” (1) In other words, “The data suggest that an increasing number of U.S. adolescents lack HSV-1 antibodies at their first sexual encounter and are therefore more susceptible to genital herpes resulting from that strain.” (1)

Click to learn more about herpes symptoms.

The Center for the Biology of Chronic Disease (CBCD) recommends that anyone concerned about genital herpes, whether caused by HSV-1 or HSV-2, take Gene-Eden-VIR or Novirin against the latent form of the virus. The formula of these natural antiviral products was shown to reduce HSV symptoms in two separate post-marketing clinical studies that followed FDA guidelines. Additionally, it was designed to help the immune system target the latent form of the virus.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the family of herpes viruses, including HSV-1 and HSV-2. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with (HSV-1 or HSV-2)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinensis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

Note: Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality and more expensive ingredients.

It is important to note, the study authors wrote that “In combination with increased oral sex behaviors among young people, “this means that adolescents may be more likely than those in previous time periods to genitally acquire HSV-1.” (1) In an accompanying editorial, David W. Kimberlin, MD, at the University of Alabama at Birmingham, wrote that “An unintended consequence of the success of public campaigns to limit the spread of HIV has led some to embrace the notion that oral sex is “safe,” Dr. Kimberlin wrote, despite the fact that oral sex also carries risks, including significant risk of transmission of HSV-1 from the mouth to the genitals. (1)

What treatments are available for herpes infections?

“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (2) There are also the natural supplements Novirin and Gene-Eden-VIR, which have a formula that was designed to help the immune system target the herpes virus when it is in a latent form.

The CBCD reminds the public that Gene-Eden-VIR and Novirin are not a cure. However, two clinical studies, published in peer reviewed medical journals showed that their formula decreases symptoms in infected individuals. Specifically, the formula of Gene-Eden-VIR and Novirin was shown to safely and effectively reduce herpes symptoms. Additionally, it was designed to help the immune system target the latent virus.

“We recommend that individuals who are infected with a latent herpes virus, take Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) "More U.S. Teens Susceptible to HSV-1 Infection, A Growing Cause of Genital Herpes" The Journal of Infectious Diseases - Published October 17, 2013
idsociety.org

(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.